Navigation Links
New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
Date:9/21/2010

MOUNTAIN VIEW, Calif., Sept. 21 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced positive top-line results from a two-year study of QNEXA® (phentermine/topiramate) Controlled Release Capsules, an investigational therapy for treatment of obesity, a condition that affects approximately one-third of adult Americans.

The findings come from the SEQUEL study (OB-305), a 52-week extension study for a subset of patients who completed the previously reported 56-week CONQUER study. The total study period was 108 weeks. SEQUEL included 675 obese or overweight patients, all of whom had two or more weight related co-morbidities, and an average baseline BMI of 36.1.

Patients in the study taking the top dose of QNEXA achieved and maintained average weight loss through two years of 11.4% of their initial body weight, or 26 pounds (ITT-LOCF). Consistent with the first year experience, QNEXA therapy was well tolerated, with no new or unexpected adverse events. The most common side effects seen were constipation, tingling, dry mouth, altered taste and insomnia.

Weight loss with QNEXA in SEQUEL was associated with statistically significant improvements in weight-related co-morbidities such as hypertension, dyslipidemia and diabetes. Among patients without diabetes at baseline, the incidence of new onset of type 2 diabetes was reduced by 54% and 76% (mid- and top-dose, respectively) as compared to placebo.

SEQUEL was a double-blind, placebo-controlled, three-arm, prospective study. Patients continued receiving the same treatment they had been randomized to in the CONQUER study in a blinded fashion: either once-a-day treatment with top-dose QNEXA (n=295), mid-dose QNEXA (n=153), or placebo (n=227). Throughout the 108-week treatment period, all patients were advised to follow a simple lifestyle modification program including reduction of food intake by
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Study of Long-Term Efficacy and Safety of New PyratineXR™ Moisturizing Lotion Featured in Journal of Drugs in Dermatology
2. Partnership for Quality Medical Donations Commits to Long-Term Recovery in Haiti
3. Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
4. FIRMAGON® Results in Fast, Long-Term Suppression of Testosterone in Prostate Cancer Patients Without Initial Testosterone Surge
5. FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors
6. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
7. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
8. Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study
9. Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
10. Keryx Reports Results of Open Label Extension Study Examining Long-Term Use of Zerenex, an Iron-Based Phosphate Binder, for the Treatment of Hyperphosphatemia
11. Abbotts XIENCE V(R) Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long-Term Safety Results in SPIRIT III Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014 , ... a hub of information concerning the biopharmaceutical Group,s national and ... further addition to the recently launched institutional website that is ... been enriched by a new chapter in the fascinating story ... richly detailed and panoramic hub on the world of clinical ...
(Date:12/17/2014)... 17, 2014  IGI Laboratories, Inc. (NYSE MKT: IG; ... its offering of $125 million aggregate principal amount of ... Notes were offered and sold only to qualified institutional ... of 1933, as amended (the "Securities Act"). ... 3.75% per year, payable semiannually in arrears on June ...
(Date:12/17/2014)... and RALEIGH, N.C. , ... Communications, LLC (CTMC), and Integrated Clinical Trial Services, ... and retention for clinical trials announce that they ... Trial Marketing Services (i-CTMS). i-CTMS will provide a ... to pharmaceutical, biotechnology and medical device companies. ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3
... PARSIPPANY, N.J., Nov. 30, 2011  Watson Pharmaceuticals, Inc. (NYSE: ... Inc., has launched an authorized generic version of LIPITOR® ... exclusive agreement with Pfizer Inc.  Watson began shipping the ... adjunct to diet to reduce elevated total cholesterol, LDL, ...
... 2011  Vantage Health (OTC:BB – ticker symbol VNTH), ("Company"), ... Health Tanzania Limited ("VHTL"), was awarded Lot 1, Lot ... es Salaam ("University") pharmaceutical and medical supply tender number ... value for lot 1, lot 2 and lot 3 ...
Cached Medicine Technology:Watson Launches Generic LIPITOR® 2Watson Launches Generic LIPITOR® 3Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply Tender 2Vantage Health 51% Owned Tanzanian Subsidiary Awarded Lot 1, Lot 2 and Lot 3 of University of Dar Es Salaam Pharmaceutical and Medical Supply Tender 3
(Date:12/19/2014)... Dennis Thompson ... News) -- Ebola,s entrance into the United States -- ... League,s mumps outbreak -- have highlighted cracks in the ... a new health policy report released Thursday. Half ... and respond to infectious disease outbreaks. That was the ...
(Date:12/19/2014)... The global magnetic resonance imaging ... that is saturated with numerous players developing innovative ... well as non-invasive nature, MRI systems have seen ... the healthcare market. Rapid advances in the field ... technologies have greatly expanded the potential of therapeutic ...
(Date:12/19/2014)... December 19, 2014 Pain Free Living ... excited to announce a new Superior magnetic necklace ... These are the strongest neodymium magnets for the fastest ... Living developed the Superior Magnetics brand for the fastest ... Living performs magnetic therapy using Superior Magnetic Jewelry at ...
(Date:12/19/2014)... Slone Partners , a national recruitment firm ... and laboratory testing industries, has promoted Leslie Loveless ... announcement comes after a year of expansion by ... Boston and several new additions to the team. ... experience," said Adam Slone, Chief Executive Officer. “Diagnostics ...
(Date:12/19/2014)... Consilium Staffing, Your Partner in ... for Federal Health Professionals annual meeting in Washington, ... military and federal healthcare providers. , In ... Business Engagement (NVSBE) conference last week in Atlanta, ... vital solution in addressing our nation’s shortage of ...
Breaking Medicine News(10 mins):Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 2Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 3Health News:Most States Not Ready to Handle Infectious Disease Outbreaks: Report 4Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 2Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 3Health News:Magnetic Resonance Imaging Systems Market Analysis and Forecast to 2020 Report at RnRMarketReserach.com 4Health News:New Superior Magnetic Necklace Relieves Migraine Headache 2Health News:Slone Partners Promotes Leslie Loveless to Chief Operating Officer 2Health News:Consilium Staffing Increasing Awareness of Locum Tenens through Conference Appearances 2
... for Medicaid, Child Health Plus, Family Health PlusTARRYTOWN, N.Y., May ... www.EnrollNY.org -- allows uninsured New Yorkers ... for the first time -- connects users to health plans ... of New York City,s five boroughs and six upstate counties ...
... (NYSE: IMA ), a global leader in enabling ... the merger of rapid diagnostics and health management, announced today ... Lynch 2009 Health Care Conference being held May 12 through ... Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice ...
... 7 Eclipsemed Ltd, a leading national distributor ... of Germany, a leading manufacturer of medical and aesthetic devices ... be featured on the Lifetime Network,s The Balancing ... women and women,s issues. The program will air on Tuesday, ...
... of Chicago,s Make a Statement: Design for the Cure event ... from the hit reality television series "Project Runway," is participating ... Design for the Cure event representing Living Positive ... At the event on Thursday, May 7th , ...
... Community Outreach Efforts Evident in First Quarter ResultsHARRISBURG, ... Concordia, today announced that its 2009 community outreach ... dental care to the underserved in the first ... it even more difficult for the uninsured community ...
... Participates in Mother,s Day Walk to Empower and Makes ... Help Ensure No One Faces Breast Cancer AlonePHILADELPHIA, May ... Care North America, which markets bladder control products and ... brand (formerly known as Serenity(R)), is teaming up with ...
Cached Medicine News:Health News:EnrollNY(TM): Easy Way for Uninsured New Yorkers to Find Free and Low-Cost Health Insurance 2Health News:Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009 2Health News:Body-Jet(R), State of the Art Water-Jet Assisted Liposuction Technology to be Featured on Lifetime Television Network, The Balancing Act 2Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 2Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 3Health News:'Project Runway' Designer in Chicago to Educate About Living with HIV and Combat Stigma Associated with the Disease 4Health News:United Concordia Provides $100,000 in Free Dental Services 2Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 2Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 3Health News:Breast Cancer Network of Strength(R) and SCA Personal Care North America, Through Its TENA(R) Brand, Team Up to Offer Support to Women Affected by Breast Cancer 4
Provides access via PDA to determine whether imaging examinations are necessary based on symptons and which studies will generate the most information....
PDA-version of the standard reference work in rheumatology....
PDA version of the best-selling guide....
More than 200 key diagnostic and treatment tables culled from Tierney's Current Medical Diagnostics and Treatment 2003....
Medicine Products: